Nautilus Biotechnology Inc. (NASDAQ:NAUT) price on Friday, August 06, fall -7.15% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.66.
A look at the stock’s price movement, the level at last check in today’s session was $8.25, moving within a range at $7.34 and $12.38. Turning to its 52-week performance, $25.89 and $7.28 were the 52-week high and 52-week low respectively. Overall, NAUT moved -16.67% over the past month.
Nautilus Biotechnology Inc.’s market cap currently stands at around $1.04 billion.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that NAUT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 1 recommend NAUT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
NAUT’s current price about -12.46% and -19.63% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 32.74, while 7-day volatility ratio is 19.32% and 8.77% in the 30-day chart. Further, Nautilus Biotechnology Inc. (NAUT) has a beta value of 0, and an average true range (ATR) of 0.84. Analysts have given the company’s stock an average 52-week price target of $11.50, forecast between a low of $10.00 and high of $13.00. Looking at the price targets, the low is -30.55% off recent price level in today’s trading while to achieve the yearly target high, it has to move -69.71%. Nonetheless, investors will most likely welcome a -50.13% jump to $11.50 which is the analysts’ median price.
In the market, a comparison of Nautilus Biotechnology Inc. (NAUT) and its peers suggest the former has performed considerably weaker. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.08% and 0.36% respectively on the day as seen in early trades.
If we refocus on Nautilus Biotechnology Inc. (NASDAQ:NAUT), historical trading data shows that trading volumes averaged 0.24 million over the past 10 days and 635.76K over the past 3 months. The company’s latest data on shares outstanding shows there are 124.05 million shares.
The 25.10% of Nautilus Biotechnology Inc.’s shares are in the hands of company insiders while institutional holders own 37.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.29 million on Jun 14, 2021, giving us a short ratio of 1.16. The data shows that as of Jun 14, 2021 short interest in Nautilus Biotechnology Inc. (NAUT) stood at 0.23% of shares outstanding. Current price change has pushed the stock -23.96% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NAUT stock continues to rise going into the next quarter.